MARK ADELMAN, M.D.; EDWARD F. HAPONIK, M.D.; EUGENE R. BLEECKER, M.D.; E. JAMES BRITT, M.D.
ADELMAN M, HAPONIK EF, BLEECKER ER, BRITT EJ. Cryptogenic Hemoptysis: Clinical Features, Bronchoscopic Findings, and Natural History in 67 Patients. Ann Intern Med. 1985;102:829-834. doi: 10.7326/0003-4819-102-6-829
Download citation file:
Published: Ann Intern Med. 1985;102(6):829-834.
We reviewed the clinical outcome of 67 patients with hemoptysis and a normal or nonlocalizing chest roentgenogram and nondiagnostic fiberoptic bronchoscopic examination. During a 38 ± 22 (SD) month period after bronchoscopy, 57 (85%) patients remained well without evidence of active tuberculosis or overlooked bronchogenic carcinoma, and 9 patients died of nonpulmonary conditions. One patient developed bronchogenic carcinoma 20 months after bronchoscopy and resolution of symptoms. Hemoptysis had resolved completely before hospital discharge in 38 (57%) patients, within 6 months in 60 (90%), and recurred in only 3. Five patients (7.5%) had intermittent episodes of bleeding for more than 1 year. Fiberoptic bronchoscopy effectively excludes specific underlying causes of hemoptysis in the setting of a normal chest roentgenogram. The prognosis for patients with cryptogenic hemoptysis is generally good, usually with resolution of bleeding within 6 months of evaluation.
Learn more about subscription options.
Register Now for a free account.
Hospital Medicine, Pulmonary/Critical Care.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only